MedTrace Logo

Iron Supplementation and Side Effects

NCT04018300 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2019-07-12

No results posted yet for this study

Summary

The objective of this study is to examine patient-reported gastrointestinal side effects, as well as iron status indicators, inflammatory markers and oxidative stress following administration of ferrous sulfate and iron-enriched Aspergillus oryzae supplementation.

Conditions

Interventions

DIETARY_SUPPLEMENT

Ferrous sulfate

65 mg Fe as ferrous sulfate

DIETARY_SUPPLEMENT

Aspiron

65 mg Fe as iron-enriched koji culture, called AspironTM

OTHER

Placebo

Contains maltodextrin.

Sponsors & Collaborators

  • Iowa State University

    lead OTHER

Principal Investigators

  • Manju B Reddy, PhD · Iowa State University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-08
Primary Completion
2018-04-18
Completion
2018-04-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04018300 on ClinicalTrials.gov